Literature DB >> 19473117

FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region.

Toshiyasu Koike1, Tomomi Izumikawa, Jun-Ichi Tamura, Hiroshi Kitagawa.   

Abstract

2-O-phosphorylation of xylose has been detected in the glycosaminoglycan-protein linkage region, GlcAbeta1-3Galbeta1-3Galbeta1-4Xylbeta1-O-Ser, of proteoglycans. Recent mutant analyses in zebrafish suggest that xylosyltransferase I and FAM20B, a protein of unknown function that shows weak similarity to a Golgi kinase encoded by four-jointed, operate in a linear pathway for proteoglycan production. In the present study, we identified FAM20B as a kinase that phosphorylates the xylose residue in the linkage region. Overexpression of FAM20B increased the amount of both chondroitin sulfate and heparan sulfate in HeLa cells, whereas the RNA interference of FAM20B resulted in a reduction of their amount in the cells. Gel-filtration analysis of the glycosaminoglycan chains synthesized in the overexpressing cells revealed that the glycosaminoglycan chains had a similar length to those in mock-transfected cells. These results suggest that FAM20B regulates the number of glycosaminoglycan chains by phosphorylating the xylose residue in the glycosaminoglycan-protein linkage region of proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473117     DOI: 10.1042/BJ20090474

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  66 in total

Review 1.  Proteoglycomics: recent progress and future challenges.

Authors:  Mellisa Ly; Tatiana N Laremore; Robert J Linhardt
Journal:  OMICS       Date:  2010-08

2.  Secreted protein kinases?

Authors:  Shih-Kai Wang; Andrew C Samann; James P Simmer
Journal:  Trends Biochem Sci       Date:  2013-09       Impact factor: 13.807

3.  Positive Mode LC-MS/MS Analysis of Chondroitin Sulfate Modified Glycopeptides Derived from Light and Heavy Chains of The Human Inter-α-Trypsin Inhibitor Complex.

Authors:  Alejandro Gomez Toledo; Jonas Nilsson; Fredrik Noborn; Carina Sihlbom; Göran Larson
Journal:  Mol Cell Proteomics       Date:  2015-09-25       Impact factor: 5.911

4.  FAM20A mutations associated with enamel renal syndrome.

Authors:  S K Wang; B M Reid; S L Dugan; J A Roggenbuck; L Read; P Aref; A P H Taheri; M Z Yeganeh; J P Simmer; J C-C Hu
Journal:  J Dent Res       Date:  2013-11-06       Impact factor: 6.116

Review 5.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

6.  GlcUAβ1-3Galβ1-3Galβ1-4Xyl(2-O-phosphate) is the preferred substrate for chondroitin N-acetylgalactosaminyltransferase-1.

Authors:  Tomomi Izumikawa; Ban Sato; Tadahisa Mikami; Jun-ichi Tamura; Michihiro Igarashi; Hiroshi Kitagawa
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 7.  Secreted protein kinases.

Authors:  Vincent S Tagliabracci; Lorenzo A Pinna; Jack E Dixon
Journal:  Trends Biochem Sci       Date:  2012-12-29       Impact factor: 13.807

8.  Binding of Clostridium botulinum C3 exoenzyme to intact cells.

Authors:  Astrid Rohrbeck; Leonie von Elsner; Sandra Hagemann; Ingo Just
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-02       Impact factor: 3.000

Review 9.  Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Authors:  Shuji Mizumoto; Shiro Ikegawa; Kazuyuki Sugahara
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Chondroitin sulfate N-acetylgalactosaminyltransferase-1 is required for normal cartilage development.

Authors:  Yumi Watanabe; Kosei Takeuchi; Susumu Higa Onaga; Michiko Sato; Mika Tsujita; Manabu Abe; Rie Natsume; Minqi Li; Tatsuya Furuichi; Mika Saeki; Tomomi Izumikawa; Ayumi Hasegawa; Minesuke Yokoyama; Shiro Ikegawa; Kenji Sakimura; Norio Amizuka; Hiroshi Kitagawa; Michihiro Igarashi
Journal:  Biochem J       Date:  2010-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.